Search alternatives:
significant complication » significant implications (Expand Search), significant application (Expand Search), significant applications (Expand Search)
complication groups » complication rates (Expand Search), complication profiles (Expand Search)
mean decrease » a decrease (Expand Search)
new decrease » nn decrease (Expand Search), we decrease (Expand Search), teer decrease (Expand Search)
significant complication » significant implications (Expand Search), significant application (Expand Search), significant applications (Expand Search)
complication groups » complication rates (Expand Search), complication profiles (Expand Search)
mean decrease » a decrease (Expand Search)
new decrease » nn decrease (Expand Search), we decrease (Expand Search), teer decrease (Expand Search)
-
1
-
2
Predictors for significant complications in case and control group.
Published 2021“…<p>Predictors for significant complications in case and control group.…”
-
3
Complications.
Published 2024“…The mean medication burden decreased significantly from 2.5 to 1.1 for iStent (55.0% reduction, <i>P</i><0.01) and 2.9 to 1.7 for iStent inject (46.8% reduction, <i>P</i><0.01), with no significant differences between the two groups (<i>P</i> = 0.17). …”
-
4
-
5
-
6
-
7
-
8
-
9
B2 decreases glycolytic intermediates in cells.
Published 2025“…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …”
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
Means, standard deviations, ranges, and frequencies for the sample’s demographic characteristics.
Published 2022Subjects: